Thomas DM - Search Results

1

Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells.

Cain JE, McCaw A, Jayasekara WS, Rossello FJ, Marini KD, Irving AT, Kansara M, Thomas DM, Ashley DM, Watkins DN. Cain JE, et al. Among authors: thomas dm. Sarcoma. 2013;2013:608964. doi: 10.1155/2013/608964. Epub 2013 Feb 28. Sarcoma. 2013. PMID: 23533324 Free PMC article.

2

Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Morgan T, Atkins GJ, Trivett MK, Johnson SA, Kansara M, Schlicht SL, Slavin JL, Simmons P, Dickinson I, Powell G, Choong PF, Holloway AJ, Thomas DM. Morgan T, et al. Among authors: thomas dm. Am J Pathol. 2005 Jul;167(1):117-28. doi: 10.1016/s0002-9440(10)62959-8. Am J Pathol. 2005. PMID: 15972958 Free PMC article.

3

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.

Cullinane C, Dorow DS, Kansara M, Conus N, Binns D, Hicks RJ, Ashman LK, McArthur GA, Thomas DM. Cullinane C, et al. Among authors: thomas dm. Cancer Res. 2005 Nov 1;65(21):9633-6. doi: 10.1158/0008-5472.CAN-05-2285. Cancer Res. 2005. PMID: 16266981 Free article.

4

Epigenetic modifications in osteogenic differentiation and transformation.

Thomas D, Kansara M. Thomas D, et al. J Cell Biochem. 2006 Jul 1;98(4):757-69. doi: 10.1002/jcb.20850. J Cell Biochem. 2006. PMID: 16598744 Review.

5

Molecular pathogenesis of osteosarcoma.

Kansara M, Thomas DM. Kansara M, et al. Among authors: thomas dm. DNA Cell Biol. 2007 Jan;26(1):1-18. doi: 10.1089/dna.2006.0505. DNA Cell Biol. 2007. PMID: 17263592 Review.

6

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.

Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM. Kansara M, et al. Among authors: thomas dm. J Clin Invest. 2009 Apr;119(4):837-51. doi: 10.1172/JCI37175. Epub 2009 Mar 23. J Clin Invest. 2009. PMID: 19307728 Free PMC article.

7

Liposarcoma: molecular genetics and therapeutics.

Conyers R, Young S, Thomas DM. Conyers R, et al. Among authors: thomas dm. Sarcoma. 2011;2011:483154. doi: 10.1155/2011/483154. Epub 2010 Dec 27. Sarcoma. 2011. PMID: 21253554 Free PMC article.

8

Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma.

Kelleher FC, Cain JE, Healy JM, Watkins DN, Thomas DM. Kelleher FC, et al. Among authors: thomas dm. Pharmacol Ther. 2012 Nov;136(2):153-68. doi: 10.1016/j.pharmthera.2012.08.004. Epub 2012 Aug 11. Pharmacol Ther. 2012. PMID: 22906929 Review.

9

Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma.

Paget C, Duret H, Ngiow SF, Kansara M, Thomas DM, Smyth MJ. Paget C, et al. Among authors: thomas dm. Oncoimmunology. 2012 Nov 1;1(8):1313-1322. doi: 10.4161/onci.21680. Oncoimmunology. 2012. PMID: 23243595 Free PMC article.

10

Next-generation sequence analysis of cancer xenograft models.

Rossello FJ, Tothill RW, Britt K, Marini KD, Falzon J, Thomas DM, Peacock CD, Marchionni L, Li J, Bennett S, Tantoso E, Brown T, Chan P, Martelotto LG, Watkins DN. Rossello FJ, et al. Among authors: thomas dm. PLoS One. 2013 Sep 26;8(9):e74432. doi: 10.1371/journal.pone.0074432. eCollection 2013. PLoS One. 2013. PMID: 24086345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters